AUVI-Q
Annual Meeting 2020 Exhibitors Video
Contact Name(s): Tanya Stamp
Phone: 804-801-2390
Email: Tanya.stamp@kaleo.com
Website: http://www.auvi-q.com

Social Media Links:

 

 

 

Resources:
Why EAI Needle Length Matters
Risk of Food Allergies in Infants and Toddlers
AUVI-Q Usability
AUVI-Q and Back To School
0.1 mg HCP Information

Company Description:
AUVI-Q® (epinephrine injection, USP) is only approved for sale in the U.S.

AUVI-Q is designed to be easy to use and to carry for whoever may be called upon to use it with innovative features like voice instructions, an auto-retractable needle and a pocket-sized design.

AUVI-Q is available in 3 dosages

0.1 mg – the first and only FDA approved epinephrine auto-injector for infants and toddlers weighing 16.5-33 lbs
0.15 mg – for children weighing 33 to 66 lbs
0.3 mg – for anyone weighing over 66 lbs

E-prescribing AUVI-Q is easy – in your EMR select ASPN for home delivery or send the prescription to your patient’s preferred Walgreens location.

Patients should seek emergency medical care after using AUVI-Q. To minimize the risk of injection-related injury, instruct caregivers to hold a young child’s or infant’s leg firmly in place when administering AUVI-Q. Visit auvi-q.com/important-safety-information to see the full AUVI-Q Indication and Important Safety Information.